[1]
M. Rebersek, “Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis”, Radiol Oncol, vol. 45, no. 4, Dec. 2011.